🔗 Share this article

Treasury head Reeves has revealed she is planning "targeted measures to tackle household expense issues" in the upcoming financial statement.

In comments to the BBC, she emphasized that reducing price rises is a collective duty of both the government and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Energy Bill Measures

Reports indicate the administration could intervene to lower energy bills, such as by cutting the current 5% level of VAT charged on energy.

An additional approach is to reduce some of the government charges currently included in household expenses.

Budgetary Limitations and Expert Expectations

The government will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these actions.

The expectation from most experts is that Reeves will have to announce higher taxes or expenditure reductions in order to meet her voluntary borrowing rules.

Previously on Thursday, analysis indicated there was a £22bn deficit for the Treasury chief to fill, which is at the more modest range of projections.

"It is a shared responsibility between the Bank of England and the government to further reduce some of the sources of price increases," Reeves told reporters in the US capital, at the conferences of the IMF and World Bank.

Revenue Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the Treasury chief said the most recent information from the OBR had not altered her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with rising international and trade concerns for the fiscal revenue measures, likely to be directed on those "with the broadest shoulders."

International Economic Disputes

Commenting on concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always take priority."

Recent announcement by Chinese authorities to strengthen export controls on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to propose an additional 100% tariff on imports from China, increasing the prospect of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary called the Chinese action "economic coercion" and "a international production control attempt."

Inquired about accepting the American proposal to join its dispute with China, the Chancellor said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the world economy and causes additional obstacles."

"In my view there are fields where we need to challenge Chinese policies, but there are also valuable prospects to trade with China's economy, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

NHS Drug Pricing and Investment

The Chancellor also recognized that the cost the National Health Service pays for pharmaceuticals could go up as a result of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or abandoning investments in the United Kingdom, with some attributing the insufficient payments they are obtaining.

Last month, the Science Minister said the price the health service spends on drugs would must rise to prevent companies and drug research funding departing from the UK.

The Chancellor told the BBC: "We have seen as a result of the payment system, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other European countries."

"We want to guarantee that people receiving treatment from the NHS are can obtain the finest critical drugs in the world. And so we are examining all of that, and... looking to obtain increased funding into Britain."